Article Information
History
- January 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Thomas Edwards1,*,
- Christopher T Williams1,
- Macrine Olwala2,
- Pauline Andang’o3,
- Walter Otieno2,
- Grace N Nalwa2,
- Abimbola Akindolire4,
- Ana I Cubas-Atienzar1,
- Toby Ross1,
- Kemi Tongo4,
- Emily R Adams1,
- Helen Nabwera5 and
- Stephen Allen5
- 1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, UK
- 2Jaramogi Oginga Odinga Teaching and Referral Hospital, Jomo Kenyatta Highway Kaloleni Kisumu KE, Central, Kenya
- 3Department of Public Health, School of Public Health and Community Development, Maseno University, Kenya
- 4College of Medicine, University of Ibadan, Nigeria
- 5Department of Clinical Sciences, Liverpool School of Tropical Medicine, UK
- ↵*Corresponding author:
Thomas Edwards. Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, UK. thomas.edwards{at}lstmed.ac.uk
Posted January 10, 2022.
Molecular surveillance reveals widespread colonisation by carbapenemase and extended spectrum beta-lactamase producing organisms in neonatal units in Kenya and Nigeria
